Losartan cough incidence

These studies demonstrate that the incidence of cough associated with losartan therapy, in a population Losartan potassium tablets USP may cause the following

losartan in patients with severe treated with ACE inhibitors, the incidence of cough reported by patients receiving losartan or

The incidence of cough is shown below. Study 1. HCTZ Losartan Lisinopril. Cough. 25%. 17%. 69%. Study 2†. Placebo Losartan Lisinopril. Cough. 35%. 29%. 62

Losartan potassium: low incidence of cough confirmed 7 Accesses Explore all metrics

Losartan potassium: low incidence of cough confirmed 7 Accesses Explore all metrics

The incidence of cough with losartan (18%) was significantly lower than with lisinopril (97%) and similar to that for metolazone (21%). Cough

by Y Lacourcière Cited by 3As shown in the Losartan Cough Study, the incidence of cough related to a treatment with an AT1 type Ang II receptor antagonist, such as losartan, is

incidence of cough in patients treated with losartan as compared to patients treated with ACE inhibitors, the incidence of cough reported by patients.

In this study, the incidence of cough reported by patients receiving losartan As observed in studies with losartan alone, adverse fetal and neonatal effects.